Abstract
C21H16BrFeNO, monoclinic, P21/c (no. 14), a = 14.6736(9) Å, b = 9.5595(6) Å, c = 12.7860(7) Å, β = 105.579(2)°, V = 1727.63(18) Å3, Z = 4, Rgt(F) = 0.0452 wRref(F2) = 0.0919, T = 170 K.
1 Source of materials
To a solution of 1-ferrocenyl-3-(4-bromophenyl)-2-propen-1-one (3.93 g, 10 mmol) and tosylmethyl isocyanide (2.15 g, 11 mmol) in N,N-dimethylformamide (25 mL) was added potassium tert-butoxide (2.24 g, 20 mmol). The mixture was stirred at room temperature for 12 h, until the TLC indicated the reaction was completed. The mixture was diluted with brine, and then extracted with ethyl acetate (3 × 30 mL). The organic phase was washed with brine (30 mL), dried with anhydrous sodium sulphate, and then concentrated under pressure. The title compound was separated by silica-gel column chromatography with ethyl acetate-petroleum ether (25 %) gradient solvent system. The target product was obtained as a white solid. For crystal growth, the product was dissolved in a minimal amount of hot ethanol and slowly cooled to room temperature (Table 1).

Data collection and handling.
Crystal: | Red block |
Size: | 0.19 × 0.13 × 0.08 mm |
Wavelength: | MoKα radiation (0.71073 Å) |
μ: | 3.19 mm−1 |
Diffractometer, scan mode: | Bruker APEX II, φ and ω scans |
θmax, completeness: | 26.4°, 100 % |
N(hkl)measured, N(hkl)unique, Rint: | 18980, 3524, 0.074 |
Criterion for Iobs, N(hkl)gt: | Iobs > 2σ(Iobs), 2341 |
N(param)refined: | 226 |
Programs: | Bruker, 1 SHELX, 2 , 3 Olex2 4 |
2 Experimental details
The crystal structure was determined using the SHELXT program, 2 and refinement was performed with the SHELXL program 3 in Olex2 software. 4 Non-hydrogen atoms underwent anisotropic refinement, while hydrogen atoms were positioned based on idealized geometry and refined using a riding model.
3 Comment
Ferrocene derivatives are of interest in organic electronics, catalysis, and material science. 5 The iron(II)-centered sandwich structure of ferrocene, where two cyclopentadienyl anions surround a central metal atom, confers a high degree of stability. 6 , 7 , 8 , 9 , 10 Specifically, the functionalization of ferrocene, such as introducing aromatic rings or heteroatoms, allows for enhanced electronic and chemical characteristics, making it useful in the design of molecular switches, sensors, and catalysts. In this context, the compound ((4-(4-bromophenyl)-1H-pyrrol-3-yl)methyl) ferrocene presents an intriguing example of ferrocene modification, featuring a bromophenyl and a pyrrole group attached to the ferrocene backbone.
The central iron atom (Fe1) is coordinated symmetrically by two cyclopentadienyl rings (C1–C5 and C2–C6), forming a classical sandwich-like structure typical of ferrocene derivatives. The bond lengths between the iron center and the carbon atoms of the cyclopentadienyl rings (Fe–C) are consistent with the typical ferrocene scaffold, averaging around 2.0 Å. These Fe–C bond distances indicate the maintenance of the characteristic electronic structure of the ferrocene core. 11 , 12 , 13 , 14 , 15 , 16
The structure features a (4-(4-bromophenyl)-1H-pyrrol-3-yl)methyl group, which is attached to the ferrocene core via a methylene linker (C11). The pyrrole ring (C11, C12, C13, N1) exhibits planarity, as expected for an aromatic heterocyclic system. The nitrogen atom (N1) is slightly displaced from the plane, likely due to electron-donating effects from the methyl group attached to C13. The pyrrole group, together with the adjacent bromophenyl unit, serves as an electron-rich region that modulates the reactivity of the ferrocene core, potentially allowing for further functionalization or interactions with electrophilic reagents.
The bromophenyl group (C14–C16, C18–C21) is attached to the pyrrole ring at position 4. The bond lengths and angles in this aromatic region follow typical values for a substituted phenyl ring, with C–C bond lengths around 1.39 Å and bond angles close to 120°, consistent with the sp2 hybridization of the carbon atoms.
The C11–O1 bond between the pyrrole ring and the oxygen atom (O1) adds a distinctive feature to the structure. The bond length for C11–O1 is approximately 1.236 Å, which is typical for a C–O single bond. The oxygen atom (O1) is positioned in such a way that it could participate in potential hydrogen bonding or dipole-dipole interactions, especially in polar solvents.
Acknowledgments
This work was financially supported by the Scientific Research Project of 2024 Youth Innovation Team of the Shaanxi Province Education Department (24JP016), the 2023 research and development project of the Xianyang Science and Technology Bureau (L2023–ZDYF–SF-030), Key Laboratory of Molecular Imaging and Drug Synthesis of Xianyang city (2021QXNL–PT-0008), School-level Scientific and Technological Innovation Team for Design, Synthesis and Structural Modification of Drug Molecules (2024KCTD04).
References
1. Bruker. SAINT, APEX2 and SADABS; Bruker AXS Inc.: Madison, WI, USA, 2012.Search in Google Scholar
2. Sheldrick, G. M. SHELXT – Integrated Space-Group and Crystal-Structure Determination. Acta Crystallogr. 2015, A71, 3–8; https://doi.org/10.1107/s2053273314026370.Search in Google Scholar PubMed PubMed Central
3. Sheldrick, G. M. Crystal Structure Refinement with SHELXL. Acta Crystallogr. 2015, C71, 3–8; https://doi.org/10.1107/s2053229614024218.Search in Google Scholar
4. Dolomanov, O. V.; Bourhis, L. J.; Gildea, R. J.; Howard, J. A.; Puschmann, H. OLEX2: A Complete Structure Solution, Refinement and Analysis Program. J. Appl. Crystallogr. 2009, 42, 339–341; https://doi.org/10.1107/s0021889808042726.Search in Google Scholar
5. Štěpnička, P. Forever Young: the First Seventy Years of Ferrocene. Dalton Trans. 2022, 51, 8085–8102; https://doi.org/10.1039/d2dt00903j.Search in Google Scholar PubMed
6. Chen, Z.-F.; Zou, H.-L.; Liang, H.; Yuan, R.-X.; Zhang, Y. Ferrocenecarbaldehyde Isonicotinyl Hydrazide. Appl. Organomet. Chem. 2004, 18, 438–439; https://doi.org/10.1002/aoc.691.Search in Google Scholar
7. Savani, C. J.; Roy, H.; Verma, S. K.; Vennapu, D. R.; Singh, V. K. Synthesis, Characterization and Evaluation of Novel Ferrocenylmethylamine Derivatives as Cytotoxic Agents. Appl. Organomet. Chem. 2021, 35, e6137; https://doi.org/10.1002/aoc.6137.Search in Google Scholar
8. Shameem, M. A.; Esfandiarfard, K.; Öberg, E.; Ott, S.; Orthaber, A. Direct, Sequential, and Stereoselective Alkynylation of C, C-Dibromophosphaalkenes. Chem. – Eur. J. 2016, 22, 10614–10619; https://doi.org/10.1002/chem.201601955.Search in Google Scholar PubMed
9. Peng, Y.-D.; Zhou, L.-S.; Chen, L.-L.; Ma, L.; Zhao, Y.; Zhang, W.-W.; Zuo, J.-L. Ferrocene-isocoumarin Conjugated Molecules: Synthesis, Structural Characterization, Electronic Properties, and DFT–TDDFT Computational Study. Dalton Trans. 2015, 44, 14465–14474; https://doi.org/10.1039/c5dt02169c.Search in Google Scholar PubMed
10. Chamkin, A. A.; Krivykh, V. V.; Nikitin, O. M.; Kreindlin, A. Z.; Shteltser, N. A.; Dolgushin, F. M.; Artyushin, O. I.; Ikonnikov, N. S.; Borisov, Y. A.; Belousov, Y. A.; Ustynyuk, N. A. Direct Phosphination of Ferrocenium Ion with Tertiary Phosphines by the Mechanism of Oxidative Nucleophilic Substitution. Eur. J. Inorg. Chem. 2018, 2018, 4494–4504; https://doi.org/10.1002/ejic.201800961.Search in Google Scholar
11. Shafir, A.; Fiedler, D.; Arnold, J. Formation of 1 : 1 Complexes of Ferrocene-Containing Salen Ligands with Mg, Ti and Zr. J. Chem. Soc., Dalton Trans. 2002, 555–560; https://doi.org/10.1039/b107066p.Search in Google Scholar
12. Zhang, C.; Zhu, Z.; Tang, W.; Xu, X.; Liu, B. Crystal Structure of (4-(2-Chlorophenyl)-1H-Pyrrol-3-Yl)(ferrocenyl) Methanone, C21H16ClFeNO. Z. Kristallogr. New Cryst. Struct. 2024, 239, 375–377; https://doi.org/10.1515/ncrs-2024-0007.Search in Google Scholar
13. Deck, P. A.; Kroll, C. E.; Gary Hollis, W.; Fronczek, F. R. Conformational Control of Intramolecular Arene Stacking in Ferrocene Complexes Bearing Tert-Butyl and Pentafluorophenyl Substituents. J. Organomet. Chem. 2001, 637–639, 107–115; https://doi.org/10.1016/s0022-328x(01)00878-6.Search in Google Scholar
14. Panaka, S.; Trivedi, R.; Jaipal, K.; Giribabu, L.; Sujitha, P.; Kumar, C. G.; Sridhar, B. Ferrocenyl Chalcogeno (Sugar) Triazole Conjugates: Synthesis, Characterization and Anticancer Properties. J. Organomet. Chem. 2016, 813, 125–130; https://doi.org/10.1016/j.jorganchem.2016.04.011.Search in Google Scholar
15. Ramírez-Gómez, A.; Gutiérrez-Hernández, A. I.; Alvarado- Castillo, M. A.; Toscano, R. A.; Ortega-Alfaro, M. C.; López-Cortés, J. G. Selenoamides as Powerful Scaffold to Build Imidazo[1,5-A]pyridines Using a Grinding Protocol. J. Organomet. Chem. 2020, 919, 121315.10.1016/j.jorganchem.2020.121315Search in Google Scholar
16. Zhang, C.; Zhu, Z.; Tang, W.; Xu, X.; Liu, B. Crystal Structure of (4-(2-chlorophenyl)-1H-pyrrol-3-yl)(ferrocenyl) Methanone. Z. Kristallogr. New Cryst. Struct. 2024, 238, 375; https://doi.org/10.1515/ncrs-2024-0007.Search in Google Scholar
© 2025 the author(s), published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Articles in the same Issue
- Frontmatter
- New Crystal Structures
- Crystal structure of 5,5′-bis(2,4,6-trinitrophenyl)-2,2′-bi(1,3,4-oxadiazole), C16H4N10O14
- Crystal structure of catena-poly[(μ3-4,4′-oxydibenzoato- κ5 O,O′: O″,O‴:O‴)-bis(2,4,6-tri(3-pyridine)-1,3,5-triazine-κ1 N)cadmium(II)], C50H32CdN12O5
- The crystal structure of 1,4-diazepane-1,4-diium potassium trinitrate, C5H14KN5O9
- The crystal structure of benzyl 2,2,5,5-tetramethylthiazolidine-4-carboxylate, C15H21NO2S
- Crystal structure of 2-hydroxyethyl-triphenylphosphonium tetracyanidoborate, C24H20BN4OP
- The crystal structure of 1-methyl-3-(N-methylnitrous amide–N-methylene) imidazolidine-2,4,5-trione
- Crystal structure of N-((3-cyano-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-(2,2,2-trifluoroacetyl)-1H-pyrazol-5-yl)carbamoyl)-2,6-difluorobenzamide, C20H7Cl2F8N5O3S
- Crystal structure of 5-(2,2-difluoropropyl)-5-methylbenzo[4,5]imidazo[2,1-a] isoquinolin-6(5H)-one, C20H18F2N2O
- The crystal structure of N′,N″-[1,2-bis(4-chlorophenyl)ethane-1,2-diylidene]bis(furan-2- carbohydrazide), C24H16Cl2N4O4
- Crystal structure of [(4-bromobenzyl)triphenylphosphonium] tetrabromoantimony(III), [C25H21BrP]+[SbBr4]−
- Crystal structure of [(4-bromobenzyl)triphenylphosphonium] tetrabromidoindium(III), [C25H21BrP]+[InBr4]−
- The crystal structure of 4-carboxy-2-oxobutan-1-aminium chloride, C5H10ClNO3
- Crystal structure of (4-(4-chlorophenyl)-1H-pyrrole-3-carbonyl)ferrocene, C21H16ClFeNO
- The crystal structure of dichlorido(η6-p-cymene)(triphenylarsine)ruthenium(II), C28H29AsCl2Ru
- Crystal structure of (Z)-2-hydroxy-N′-(1-(o-tolyl)ethylidene)benzohydrazide, C16H16N2O2
- The crystal structure of 10-(1-bromoethyl)-14-(bromomethyl)dibenzo[a, c]acridine, C24H17NBr2
- Synthesis and crystal structure of 6-methoxy-7-[(4-methoxyphenyl)methoxy]-2H-1-benzopyran-2-one, C18H16O5
- Synthesis and crystal structure of ethyl 4-((4-trifluoromethylbenzyl)amino)benzo, C17H16F3NO2
- The crystal structure of (Z)-2-(tert-butyl)-6-(7-(tert-butyl)-5-methylbenzo[d][1,3]oxathiol-2-ylidene)-4-methylcyclohexa-2,4-dien-1-one, C23H28O2S
- The crystal structure of (R)-2-aminobutanamide hydrochloride, C4H11ClN2O
- Crystal structure of bromido[hydridotris(3-tert-butyl-5-isopropylpyrazolyl)borato-κ3 N,N′,N″]copper(II), C30H52BBrCuN6
- Crystal structure of chlorido{hydridotris[3-mesityl-5-methyl-1H-pyrazol-1-yl-κN3]borato}-copper(II) dichloromethane monosolvate
- Crystal structure of 4-[3,5-bis(propan-2-yl)-1H-pyrazol-4-yl]pyridine, C14H19N3
- Crystal structure of ((4-(4-bromophenyl)-1H-pyrrol-3-yl)methyl)ferrocene, C21H16BrFeNO
- Crystal structure of [(4-chlorobenzyl)triphenylphosphonium] dichloridocopper(I), {[C25H21ClP]+[CuCl2]−}n
- The crystal structure of {Cu(2,9-diisopropyl-4,7-diphenyl-1,10-phenanthroline)[4,5-bis(diphenylphosphino)-9,9-dimethylxanthene]}+ PF6−·1.5(EtOAC)
- Crystal structure of 3,5-bis(t-butyl)-1H-pyrazol-4-amine, C11H21N3
- Crystal structure of [(2,4-dichlorobenzyl)triphenylphosphonium] trichloridocopper(II), [C25H20Cl2P]+[CuCl3]−
- The crystal structure of dipotassium sulfide, K2S
- Crystal structure of (4-(4-methoxyphenyl)-1H-pyrrole-3-carbonyl)ferrocene, C22H19FeNO2
- Crystal structure of (E)-6-(4-methylpiperazin-1-yl)-2-(4-(trifluoromethyl)benzylidene)-3, 4-dihydronaphthalen-1(2H)-one, C23H23F3N2O
- Crystal structure of (E)-6-morpholino-2-(4-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H20F3NO2
- Crystal structure of Ce9Ir37Ge25
- The crystal structure of ethyl 6-(2-nitrophenyl)imidazo[2,1-b]thiazole-3-carboxylate, C14H11N3O4S
- Crystal structure of (4-(4-isopropylphenyl)-1H-pyrrol-3-yl)(ferrocenyl)methanone, C24H23FeNO
- Crystal structure of bis(methylammonium) tetrathiotungstate(VI), (CH3NH3)2[WS4]
- Crystal structure of 6,11-dihydro-12H-benzo[e]indeno[1,2-b]oxepin-12-one, C17H12O2
- Crystal structure of 3-[(4-phenylpiperidin-1-yl)methyl]-5-(thiophen-2-yl)-2,3-dihydro-1,3,4- oxadiazole-2-thione, C18H19N3OS2
- Crystal structure of N-isopropyl-1,8-naphthalimide C15H13NO2
- TiNiSi-type EuPdBi
- Crystal structure of 1-(p-tolylphenyl)-4-(2-thienoyl)-3-methyl-1H-pyrazol-5-ol, C16H14N2O2S
- The crystal structure of 3-(3-carboxypropyl)-2-nitro-1H-pyrrole 1-oxide, C7H9N3O5
- The crystal structure of tetraaqua-bis(2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetato-k2O:N)-tetrakis(2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetato-k1N)trizinc(II) hexahydrate C36H52N18O32Zn3
- The crystal structure of 4-(3-carboxy-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)piperazin-1-ium 4-hydroxy-3,5-dimethoxybenzoate monohydrate, C25H30FN3O9
- Crystal structure of bis(DL-1-carboxy-2-(1H-indol-3-yl)ethan-1-aminium) oxalate — acetic acid (1/2)
- Crystal structure of methyl (E)-4-((4-methylphenyl)sulfonamido)but-2-enoate, C12H15NO4S
- The crystal structure of actarit, C10H11NO3
- The crystal structure of bicyclol, C19H18O9
- The crystal structure of topiroxostat, C13H8N6
- Crystal structure of 2,2-dichloro-N-methyl-N-(4-p-tolylthiazol-2-yl)acetamide, C13H12Cl2N2OS
- Crystal structure of 4-(trifluoromethyl)-7-coumarinyl trifluoromethanesulfonate C11H4F6O5S
- Crystal structure of (1,4,7,10,13,16-hexaoxacyclooctadecane-κ6O6)-((Z)-N,N′-bis(2-(dimethylamino)phenyl)carbamimidato-κ1N)potassium(I)
- Crystal structure of (Z)-2-(5-((4-(dimethylamino)naphthalen-1-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid, C18H16N2O3S2
- Crystal structure of (4-fluorobenzyl)triphenylphosphonium bromide, C25H21BrFP
- The crystal structure of dichlorido-[6-(pyridin-2-yl)phenanthridine-κ2N, N′]zinc(II)-chloroform (1/1), C19H13N2ZnCl5
- Crystal structure of (E)-(3-(2,4-dichlorophenyl)acryloyl)ferrocene, C19H14Cl2FeO
- The crystal structure of (E)-7-chloro-1-cyclopropyl-6-fluoro-3-((2-hydroxybenzylidene)amino)quinolin-4(1H)-one, C19H14ClFN2O2
- Crystal structure of 2-bromo-11-(((fluoromethyl)sulfonyl)methyl)-6-methyl-6,11-dihydrodibenzo[c,f][1,2]thiazepine 5,5-dioxide, C16H13BrFNO4S2
- Crystal structure of 2-chloro-11-(((fluoromethyl)sulfonyl)methyl)-6-methyl-6,11-dihydrodibenzo[c,f][1,2]thiazepine 5,5-dioxide, C16H13ClFNO4S2
- Crystal structure of 5-(2,2-difluoropropyl)-5-methyl-6-oxo-5,6-dihydrobenzo[4,5]imidazo[2,1-a]isoquinoline-3-carbonitrile, C20H15F2N3O
Articles in the same Issue
- Frontmatter
- New Crystal Structures
- Crystal structure of 5,5′-bis(2,4,6-trinitrophenyl)-2,2′-bi(1,3,4-oxadiazole), C16H4N10O14
- Crystal structure of catena-poly[(μ3-4,4′-oxydibenzoato- κ5 O,O′: O″,O‴:O‴)-bis(2,4,6-tri(3-pyridine)-1,3,5-triazine-κ1 N)cadmium(II)], C50H32CdN12O5
- The crystal structure of 1,4-diazepane-1,4-diium potassium trinitrate, C5H14KN5O9
- The crystal structure of benzyl 2,2,5,5-tetramethylthiazolidine-4-carboxylate, C15H21NO2S
- Crystal structure of 2-hydroxyethyl-triphenylphosphonium tetracyanidoborate, C24H20BN4OP
- The crystal structure of 1-methyl-3-(N-methylnitrous amide–N-methylene) imidazolidine-2,4,5-trione
- Crystal structure of N-((3-cyano-1-(2,6-dichloro-4-(trifluoromethyl)phenyl)-4-(2,2,2-trifluoroacetyl)-1H-pyrazol-5-yl)carbamoyl)-2,6-difluorobenzamide, C20H7Cl2F8N5O3S
- Crystal structure of 5-(2,2-difluoropropyl)-5-methylbenzo[4,5]imidazo[2,1-a] isoquinolin-6(5H)-one, C20H18F2N2O
- The crystal structure of N′,N″-[1,2-bis(4-chlorophenyl)ethane-1,2-diylidene]bis(furan-2- carbohydrazide), C24H16Cl2N4O4
- Crystal structure of [(4-bromobenzyl)triphenylphosphonium] tetrabromoantimony(III), [C25H21BrP]+[SbBr4]−
- Crystal structure of [(4-bromobenzyl)triphenylphosphonium] tetrabromidoindium(III), [C25H21BrP]+[InBr4]−
- The crystal structure of 4-carboxy-2-oxobutan-1-aminium chloride, C5H10ClNO3
- Crystal structure of (4-(4-chlorophenyl)-1H-pyrrole-3-carbonyl)ferrocene, C21H16ClFeNO
- The crystal structure of dichlorido(η6-p-cymene)(triphenylarsine)ruthenium(II), C28H29AsCl2Ru
- Crystal structure of (Z)-2-hydroxy-N′-(1-(o-tolyl)ethylidene)benzohydrazide, C16H16N2O2
- The crystal structure of 10-(1-bromoethyl)-14-(bromomethyl)dibenzo[a, c]acridine, C24H17NBr2
- Synthesis and crystal structure of 6-methoxy-7-[(4-methoxyphenyl)methoxy]-2H-1-benzopyran-2-one, C18H16O5
- Synthesis and crystal structure of ethyl 4-((4-trifluoromethylbenzyl)amino)benzo, C17H16F3NO2
- The crystal structure of (Z)-2-(tert-butyl)-6-(7-(tert-butyl)-5-methylbenzo[d][1,3]oxathiol-2-ylidene)-4-methylcyclohexa-2,4-dien-1-one, C23H28O2S
- The crystal structure of (R)-2-aminobutanamide hydrochloride, C4H11ClN2O
- Crystal structure of bromido[hydridotris(3-tert-butyl-5-isopropylpyrazolyl)borato-κ3 N,N′,N″]copper(II), C30H52BBrCuN6
- Crystal structure of chlorido{hydridotris[3-mesityl-5-methyl-1H-pyrazol-1-yl-κN3]borato}-copper(II) dichloromethane monosolvate
- Crystal structure of 4-[3,5-bis(propan-2-yl)-1H-pyrazol-4-yl]pyridine, C14H19N3
- Crystal structure of ((4-(4-bromophenyl)-1H-pyrrol-3-yl)methyl)ferrocene, C21H16BrFeNO
- Crystal structure of [(4-chlorobenzyl)triphenylphosphonium] dichloridocopper(I), {[C25H21ClP]+[CuCl2]−}n
- The crystal structure of {Cu(2,9-diisopropyl-4,7-diphenyl-1,10-phenanthroline)[4,5-bis(diphenylphosphino)-9,9-dimethylxanthene]}+ PF6−·1.5(EtOAC)
- Crystal structure of 3,5-bis(t-butyl)-1H-pyrazol-4-amine, C11H21N3
- Crystal structure of [(2,4-dichlorobenzyl)triphenylphosphonium] trichloridocopper(II), [C25H20Cl2P]+[CuCl3]−
- The crystal structure of dipotassium sulfide, K2S
- Crystal structure of (4-(4-methoxyphenyl)-1H-pyrrole-3-carbonyl)ferrocene, C22H19FeNO2
- Crystal structure of (E)-6-(4-methylpiperazin-1-yl)-2-(4-(trifluoromethyl)benzylidene)-3, 4-dihydronaphthalen-1(2H)-one, C23H23F3N2O
- Crystal structure of (E)-6-morpholino-2-(4-(trifluoromethyl)benzylidene)-3,4-dihydronaphthalen-1(2H)-one, C22H20F3NO2
- Crystal structure of Ce9Ir37Ge25
- The crystal structure of ethyl 6-(2-nitrophenyl)imidazo[2,1-b]thiazole-3-carboxylate, C14H11N3O4S
- Crystal structure of (4-(4-isopropylphenyl)-1H-pyrrol-3-yl)(ferrocenyl)methanone, C24H23FeNO
- Crystal structure of bis(methylammonium) tetrathiotungstate(VI), (CH3NH3)2[WS4]
- Crystal structure of 6,11-dihydro-12H-benzo[e]indeno[1,2-b]oxepin-12-one, C17H12O2
- Crystal structure of 3-[(4-phenylpiperidin-1-yl)methyl]-5-(thiophen-2-yl)-2,3-dihydro-1,3,4- oxadiazole-2-thione, C18H19N3OS2
- Crystal structure of N-isopropyl-1,8-naphthalimide C15H13NO2
- TiNiSi-type EuPdBi
- Crystal structure of 1-(p-tolylphenyl)-4-(2-thienoyl)-3-methyl-1H-pyrazol-5-ol, C16H14N2O2S
- The crystal structure of 3-(3-carboxypropyl)-2-nitro-1H-pyrrole 1-oxide, C7H9N3O5
- The crystal structure of tetraaqua-bis(2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetato-k2O:N)-tetrakis(2-(2-methyl-5-nitro-1H-imidazol-1-yl)acetato-k1N)trizinc(II) hexahydrate C36H52N18O32Zn3
- The crystal structure of 4-(3-carboxy-1-ethyl-6-fluoro-4-oxo-1,4-dihydroquinolin-7-yl)piperazin-1-ium 4-hydroxy-3,5-dimethoxybenzoate monohydrate, C25H30FN3O9
- Crystal structure of bis(DL-1-carboxy-2-(1H-indol-3-yl)ethan-1-aminium) oxalate — acetic acid (1/2)
- Crystal structure of methyl (E)-4-((4-methylphenyl)sulfonamido)but-2-enoate, C12H15NO4S
- The crystal structure of actarit, C10H11NO3
- The crystal structure of bicyclol, C19H18O9
- The crystal structure of topiroxostat, C13H8N6
- Crystal structure of 2,2-dichloro-N-methyl-N-(4-p-tolylthiazol-2-yl)acetamide, C13H12Cl2N2OS
- Crystal structure of 4-(trifluoromethyl)-7-coumarinyl trifluoromethanesulfonate C11H4F6O5S
- Crystal structure of (1,4,7,10,13,16-hexaoxacyclooctadecane-κ6O6)-((Z)-N,N′-bis(2-(dimethylamino)phenyl)carbamimidato-κ1N)potassium(I)
- Crystal structure of (Z)-2-(5-((4-(dimethylamino)naphthalen-1-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)acetic acid, C18H16N2O3S2
- Crystal structure of (4-fluorobenzyl)triphenylphosphonium bromide, C25H21BrFP
- The crystal structure of dichlorido-[6-(pyridin-2-yl)phenanthridine-κ2N, N′]zinc(II)-chloroform (1/1), C19H13N2ZnCl5
- Crystal structure of (E)-(3-(2,4-dichlorophenyl)acryloyl)ferrocene, C19H14Cl2FeO
- The crystal structure of (E)-7-chloro-1-cyclopropyl-6-fluoro-3-((2-hydroxybenzylidene)amino)quinolin-4(1H)-one, C19H14ClFN2O2
- Crystal structure of 2-bromo-11-(((fluoromethyl)sulfonyl)methyl)-6-methyl-6,11-dihydrodibenzo[c,f][1,2]thiazepine 5,5-dioxide, C16H13BrFNO4S2
- Crystal structure of 2-chloro-11-(((fluoromethyl)sulfonyl)methyl)-6-methyl-6,11-dihydrodibenzo[c,f][1,2]thiazepine 5,5-dioxide, C16H13ClFNO4S2
- Crystal structure of 5-(2,2-difluoropropyl)-5-methyl-6-oxo-5,6-dihydrobenzo[4,5]imidazo[2,1-a]isoquinoline-3-carbonitrile, C20H15F2N3O